Evaxion: EVX-01 Ready to Start Phase II (Redeye)
2022-01-19 10:00
Redeye comments on the regulatory clearance to start the planned phase II trial for the flagship product EVX-01 in combination with pembrolizumab.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se